Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas H Taylor

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Plos One|March 20, 2010
Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) diseaseOliver W Morgan, Anna Bramley, Ashley Fowlkes, et al.
Journal of Clinical Microbiology|January 13, 2004
Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidisElizabeth A Mothershed, Claudio T Sacchi, Anne M Whitney, et al.
The New England Journal of Medicine|June 13, 2013
Therapies for active rheumatoid arthritis after methotrexate failureJames R O'Dell, Ted R Mikuls, Thomas H Taylor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trialWilliam B Armstrong, Thomas H Taylor, Ann R Kennedy, et al.
Human Vaccines & Immunotherapeutics|September 12, 2025
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survivalDaniela A Bota, David E Piccioni, Christopher M Duma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired PneumoniaPreeta K Kutty, Seema Jain, Thomas H Taylor, et al.
Contemporary Clinical Trials|September 1, 2022
A digital approach to asthma self-management in adults: Protocol for a pragmatic randomized controlled trialJordan Silberman, Siavash Sarlati, Bronwyn Harris, et al.
American Journal of Epidemiology|September 7, 2012
The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009Saumil S Doshi, Kendra E Stauffer, Amy Parker Fiebelkorn, et al.
Frontiers in Oncology|July 15, 2022
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and TemozolomideDaniela A Bota, Thomas H Taylor, Naomi Lomeli, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 14, 2022
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessmentDaniela A Bota, Thomas H Taylor, David E Piccioni, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Plos One|March 20, 2010
Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) diseaseOliver W Morgan, Anna Bramley, Ashley Fowlkes, et al.
Journal of Clinical Microbiology|January 13, 2004
Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidisElizabeth A Mothershed, Claudio T Sacchi, Anne M Whitney, et al.
The New England Journal of Medicine|June 13, 2013
Therapies for active rheumatoid arthritis after methotrexate failureJames R O'Dell, Ted R Mikuls, Thomas H Taylor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trialWilliam B Armstrong, Thomas H Taylor, Ann R Kennedy, et al.
Human Vaccines & Immunotherapeutics|September 12, 2025
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survivalDaniela A Bota, David E Piccioni, Christopher M Duma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired PneumoniaPreeta K Kutty, Seema Jain, Thomas H Taylor, et al.
Contemporary Clinical Trials|September 1, 2022
A digital approach to asthma self-management in adults: Protocol for a pragmatic randomized controlled trialJordan Silberman, Siavash Sarlati, Bronwyn Harris, et al.
American Journal of Epidemiology|September 7, 2012
The burden and severity of illness due to 2009 pandemic influenza A (H1N1) in a large US city during the late summer and early fall of 2009Saumil S Doshi, Kendra E Stauffer, Amy Parker Fiebelkorn, et al.
Frontiers in Oncology|July 15, 2022
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and TemozolomideDaniela A Bota, Thomas H Taylor, Naomi Lomeli, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 14, 2022
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessmentDaniela A Bota, Thomas H Taylor, David E Piccioni, et al.
Pageof 8